Activation of STAT transcription factors in oncogenic tyrosine kinase signaling

Journal of Biomedical Science

Volumn 5, Issue 2, 1998, Pages 79-85

  Garcia, Roy ^a   Jove, Richard ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cell growth; Oncogenes; Signal transduction; STAT; Transformation; Tumorigenesis; Tyrosine kinases

Indexed keywords

PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

CARCINOGENESIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031800697     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02258360     Document Type: Review

References (59)

1. Akira S, Nishio Y, Inoue M, Wang X-J, Wei S, Matsukaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71;1994.
2. Bharsar D, Cochran BH. Activation of the STAT transcription factor pathway by the Src and PDGF receptor kinases, submitted for publication.
3. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME. Regulation of gliogenesis in the central nervous system by the JAKSTAT signaling pathway. Science 278:477-483:1997.
4. Bromberg JF, Horvath CM, Beser D, Lathem WW, Darnell JE. STAT3 activation enhances cellular transformation by v-Src Mol Cell Biol. in press
5. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncog 5: 331-357;1994
6. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 66:5161-5167; 1992.
7. Campbell GS, Yu C-L, Jove R, Carter-Su C. Constitutive activation of JAK1 in Src-transformed cells. J Biol Chem 272:2591-2594; 1997.
8. Cao, X, Tay A, Guy GR, Tan YH. Activation and association of STAT3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603;1996.
9. Carlesso N, Frank DA, Griffin JD. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183: 811-820;1996.
10. Chai SK, Michols GL, Rothman P. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells from leukemia patients. J Immunol 159: 4720-4728;1997.
11. Chaturvedi P, Sharma S, Reddy EP. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol Cell Biol 17:3295-3304;1997.
12. Danial NN, Losman JA, Krishnan K, Lu T, Yip N, Krolewski J, Goff SP, Wang JYJ, Rothman PB. Jak1-interacting domain of v-Abl is required for cytokine-independent activation of STATs and proliferation, submitted for publication.
13. Danial NN, Pernis A, Rothman PB. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875-1877;1995.
14. Darnell JE. STATs and gene regulation. Science 277:1630-1635;1997.
15. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421;1994.
16. Frank DA, Varticovski L. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia 10:1724-1730;1996.
17. Fu XY, Zhang JJ. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell 74:1135-1145;1993.
18. Fukada T, Hibi M, Yamanaka Y, Takahashi M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449-460;1996.
19. Garcia R, Yu C-L, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita EJ, Ethier SP, Jove R. Constitutive activation of STAT3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8: 1267-1276;1997.
20. Gobert S, Chretien S, Gouilleux F, Muller O, Pallaed C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J 15:2434-2441; 1996.
21. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692-1697;1996.
22. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Pitt A, Tweardy DJ. Requirement of STAT3 but not STAT1 activation for EGF-R mediated cell growth, submitted for publication.
23. Hanratty WP, Dearolf CR. The Drosophila tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet 238:33-37;1993.
24. Hauser PJ, Pledger WJ. STAT3 activation is linked to p27kip1 induction in differentiating keratinocytes, submitted for publication.
25. Hou XS, Melnick MB, Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84:411-419;1996.
26. Ihle JN. STATs: Signal transducers and activators of transcription. Cell 84:331-334;1996.
27. Ilaria RL, Van Etten RA. P210 and P190 (BCR/ ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271: 31704-31710;1996.
28. Kaplan MH, Sun YL, Hoey T, Gusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in STAT4-deficient mice. Nature 380:627-630;1996.
29. Leaman DW, Leung S, Li X, Stark, GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578-1588; 1996.
30. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger, J, Kerr IM, Levy DE, Stark GR. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16:369-375;1996.
31. Liu RY, Fan C, Garcia R, Jove R, Zuckerman KS. Constitutive activation of JAK2/STAT5 signal transduction pathway in growth factor-independent megakaryocytic leucemic cell lines, submitted for publication.
32. kl. J Virol 71:6677-6682;1997.
33. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79-81; 1995.
34. Mui AL-F, Wakao H, Kinoshita T, Kitamura T, Miyajima A. Suppression of interleukin-3 induced gene expression by a c-terminal truncated STAT5: Role of STAT5 in proliferation. EMBO J 15:2425-2433;1996.
35. Nelson KL, Bowman TL, Jove R, Smithgall TE. Direct activation of STAT3 by the c-Fes protein-tyrosine kinase. J Biol Chem, in press.
36. Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N. Constitutive activation of a slowly migrating isoform of STAT3 in mycosis fungoides: tyrphostin AG490 inhibits STAT3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA 94:6764-6769;1997.
37. Ruff-Jamison S, Chen K, Cohen S. Induction by EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261:1733-1736;1993.
38. Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57:978-987; 1997.
39. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: The JAKSTAT pathway. Annu Rev Biochem 64:621-651;1995.
40. Shimozaki K, Nakajima K, Hirano T, Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 272:25184-25189;1997.
41. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247-254;1996.
42. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247-254;1996.
43. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Nail Acad Sci USA 89:232-235; 1992.
44. Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC, Rosen ST. Interferon-alpha resistance in cutaneous T cell lymphoma cell line is associated with lack of STAT1 expression, submitted for publication.
45. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 15:3801-3804;1997.
46. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura SI, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of STAT6 in IL-4 signaling. Nature 380: 627-630;1996.
47. Thirfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC, Ihle JN. Requirement for STAT4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174;1996.
48. Turkson J, Bowman T, Garcia R. Caldenhoven E, de Groot RP, Jove R. STAT3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol, in press.
49. Vignais M-L, Sadowski HB, Watling D, Rogers NC, Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16: 1759-1769;1996.
50. Wagner BJ, Haves TE, Hoban CJ, Cochran BH: The SIF binding element confers sis/ PDGF inducibility onto the c-fos promoter. EMBO J 9:4477-4484;1990.
51. Wang Y-Z, Garcia R, Jove R, Pledger WJ. Direct association of PDGF receptor and STAT3 in 3T3 fibroblasts induced by platelet-derived growth factor, submitted for publication.
52. Watson CJ, Miller WR. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer 71:840-844;1995.
53. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809-816; 1996.
54. Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809-816; 1996.
55. Yu C-L, Jove R, Burakoff SJ. Constitutive activation of the Jak-STAT pathway in T lymphoma overexpressing the Ick protein tyrosine kinase. J Immunol. in press.
56. Yu, C-L, Meyer DJ, Campbell GS, Lamer AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a STAT3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83;1995.
57. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148-8153;1996.
58. Zhong Z, Wen Z, Darnell JE Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98; 1994.
59. Zong C, Yan R, August A, Darnell JE, Hanafusa H. Unique signal transduction of Eyk: Constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J 15:4515-4525;1996.